ATENOLOL

Atenolol Adverse Events Reported to the FDA Over Time

How are Atenolol adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Atenolol, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Atenolol is flagged as the suspect drug causing the adverse event.

Most Common Atenolol Adverse Events Reported to the FDA

What are the most common Atenolol adverse events reported to the FDA?

Bradycardia	577 (2.35%)
Completed Suicide	493 (2.01%)
Hypotension	492 (2%)
Dizziness	393 (1.6%)
Syncope	343 (1.4%)
Drug Interaction	292 (1.19%)
Hypertension	284 (1.16%)
Blood Pressure Increased	281 (1.14%)
Drug Ineffective	281 (1.14%)
Dyspnoea	251 (1.02%)
Nausea	246 (1%)
	Show More
Asthenia	234 (.95%)
Overdose	221 (.9%)
Renal Failure Acute	219 (.89%)
Fatigue	209 (.85%)
Cardiac Arrest	204 (.83%)
Fall	195 (.79%)
Malaise	192 (.78%)
Diarrhoea	184 (.75%)
Vomiting	170 (.69%)
Headache	169 (.69%)
Loss Of Consciousness	147 (.6%)
Chest Pain	141 (.57%)
Oedema Peripheral	135 (.55%)
Depression	129 (.52%)
Palpitations	128 (.52%)
Pain	125 (.51%)
Sinus Bradycardia	125 (.51%)
Confusional State	123 (.5%)
Anxiety	119 (.48%)
Hyperkalaemia	116 (.47%)
Rash	111 (.45%)
Respiratory Arrest	110 (.45%)
Weight Decreased	108 (.44%)
Hyperhidrosis	107 (.44%)
Myocardial Infarction	107 (.44%)
Heart Rate Decreased	104 (.42%)
Cough	103 (.42%)
Dehydration	102 (.42%)
Myalgia	102 (.42%)
Lactic Acidosis	101 (.41%)
Lethargy	100 (.41%)
Hypoglycaemia	98 (.4%)
Renal Failure	97 (.39%)
Anaemia	96 (.39%)
Shock	96 (.39%)
Blood Creatinine Increased	95 (.39%)
Blood Pressure Decreased	92 (.37%)
Insomnia	90 (.37%)
Tremor	90 (.37%)
Multiple Drug Overdose	89 (.36%)
Depressed Level Of Consciousness	88 (.36%)
Drug Toxicity	88 (.36%)
Heart Rate Increased	87 (.35%)
Atrioventricular Block Complete	86 (.35%)
Atrial Fibrillation	84 (.34%)
Blood Glucose Increased	84 (.34%)
Blood Pressure Inadequately Control...	84 (.34%)
Cerebrovascular Accident	84 (.34%)
Metabolic Acidosis	82 (.33%)
Hypokalaemia	81 (.33%)
Poisoning	81 (.33%)
Pain In Extremity	80 (.33%)
Somnolence	80 (.33%)
Pruritus	79 (.32%)
Cardio-respiratory Arrest	77 (.31%)
Urinary Tract Infection	76 (.31%)
Feeling Abnormal	75 (.31%)
Pneumonia	75 (.31%)
Diabetes Mellitus	74 (.3%)
Gait Disturbance	72 (.29%)
Pulmonary Oedema	72 (.29%)
Condition Aggravated	69 (.28%)
Decreased Appetite	69 (.28%)
Tachycardia	69 (.28%)
Abdominal Pain	66 (.27%)
Orthostatic Hypotension	66 (.27%)
Drug Exposure During Pregnancy	65 (.26%)
Medication Error	64 (.26%)
Suicide Attempt	63 (.26%)
Weight Increased	63 (.26%)
Convulsion	62 (.25%)
Death	62 (.25%)
Rhabdomyolysis	62 (.25%)
Cardiac Failure	61 (.25%)
Intentional Overdose	61 (.25%)
Angina Pectoris	60 (.24%)
Atrioventricular Block First Degree	60 (.24%)
Cardiogenic Shock	60 (.24%)
General Physical Health Deteriorati...	60 (.24%)
Pyrexia	59 (.24%)
Drug Hypersensitivity	58 (.24%)
Paraesthesia	58 (.24%)
Arrhythmia	57 (.23%)
Chest Discomfort	56 (.23%)
Back Pain	55 (.22%)
Circulatory Collapse	54 (.22%)
Panic Attack	52 (.21%)
Renal Impairment	52 (.21%)
Aggression	51 (.21%)
Coma	51 (.21%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Atenolol, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Atenolol is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Atenolol

What are the most common Atenolol adverse events reported to the FDA?

Cardiac Arrhythmias	1747 (7.11%)
Neurological	1732 (7.05%)
Cardiac And Vascular Investigations	952 (3.87%)
Decreased And Nonspecific Blood Pre...	854 (3.47%)
Therapeutic And Nontherapeutic Effe...	736 (2.99%)
Medication Errors	709 (2.88%)
Respiratory	693 (2.82%)
Gastrointestinal Signs	691 (2.81%)
Suicidal And Self-injurious Behavio...	614 (2.5%)
Epidermal And Dermal Conditions	525 (2.14%)
Renal Disorders	482 (1.96%)
	Show More
Infections - Pathogen Unspecified	400 (1.63%)
Muscle	393 (1.6%)
Electrolyte And Fluid Balance Condi...	378 (1.54%)
Injuries	350 (1.42%)
Coronary Artery	340 (1.38%)
Vascular Hypertensive	312 (1.27%)
Anxiety Disorders	280 (1.14%)
Gastrointestinal Motility And Defec...	276 (1.12%)
Chemical Injury And Poisoning	264 (1.07%)
Hepatic And Hepatobiliary	261 (1.06%)
Physical Examination Topics	261 (1.06%)
Glucose Metabolism Disorders	249 (1.01%)
Musculoskeletal And Connective Tiss...	247 (1.01%)
Hematology Investigations	236 (.96%)
Central Nervous System Vascular	216 (.88%)
Renal And Urinary Tract Investigati...	207 (.84%)
Sleep Disorders	201 (.82%)
Cardiac Disorder Signs	199 (.81%)
Acid-base	196 (.8%)
Hepatobiliary	194 (.79%)
Skin Appendage Conditions	193 (.79%)
Headaches	190 (.77%)
Upper Respiratory Tract Disorders	177 (.72%)
Heart Failures	169 (.69%)
Movement Disorders	169 (.69%)
Lower Respiratory Tract Disorders	166 (.68%)
Bronchial Disorders	165 (.67%)
Deliria	164 (.67%)
Joint	161 (.66%)
Appetite And General Nutritional	156 (.63%)
Depressed Mood Disorders	151 (.61%)
Metabolic, Nutritional And Blood Ga...	150 (.61%)
Allergic Conditions	131 (.53%)
Mental Impairment	130 (.53%)
Urinary Tract Signs	126 (.51%)
Water, Electrolyte And Mineral	126 (.51%)
Anemias Nonhemolytic And Marrow Dep...	125 (.51%)
Vascular	118 (.48%)
Myocardial	116 (.47%)
Gastrointestinal Hemorrhages	113 (.46%)
Lifestyle Issues	111 (.45%)
Vision	106 (.43%)
Oral Soft Tissue Conditions	98 (.4%)
Psychiatric	98 (.4%)
Arteriosclerosis, Stenosis, Vascula...	95 (.39%)
Bone And Joint Injuries	95 (.39%)
Fatal Outcomes	87 (.35%)
Procedural And Device Related Injur...	84 (.34%)
Seizures	83 (.34%)
Enzyme	81 (.33%)
Product Quality Issues	79 (.32%)
Hematological And Lymphoid Tissue T...	77 (.31%)
Body Temperature Conditions	76 (.31%)
Disturbances In Thinking	75 (.31%)
Personality Disorders	74 (.3%)
Protein And Chemistry Analyses	72 (.29%)
Therapeutic Procedures And Supporti...	72 (.29%)
Gastrointestinal Inflammatory Condi...	70 (.28%)
Inner Ear And Viiith Cranial Nerve	66 (.27%)
Lipid Analyses	66 (.27%)
Toxicology And Therapeutic Drug Mon...	64 (.26%)
White Blood Cell	60 (.24%)
Neonatal And Perinatal Conditions	57 (.23%)
Angiedema And Urticaria	56 (.23%)
Peritoneal And Retroperitoneal Cond...	56 (.23%)
Lipid Metabolism	53 (.22%)
Mood Disorders	52 (.21%)
Hypothalamus And Pituitary Gland	50 (.2%)
Tongue Conditions	49 (.2%)
Nephropathies	48 (.2%)
Endocrine Investigations	47 (.19%)
Cardiac Valve	46 (.19%)
Pulmonary Vascular	46 (.19%)
Embolism And Thrombosis	44 (.18%)
Gastrointestinal Neoplasms Malignan...	43 (.17%)
Salivary Gland Conditions	42 (.17%)
Somatoform And Factitious	42 (.17%)
Viral Infectious	42 (.17%)
Bacterial Infectious	39 (.16%)
Neuromuscular	39 (.16%)
Peripheral Neuropathies	39 (.16%)
Sexual Function And Fertility	39 (.16%)
Exocrine Pancreas Conditions	38 (.15%)
Eye	38 (.15%)
Pleural	38 (.15%)
Reproductive Organ And Breast Inves...	38 (.15%)
Skin Vascular Abnormalities	38 (.15%)
Thyroid Gland	38 (.15%)
Pericardial	37 (.15%)
Connective Tissue Disorders	35 (.14%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Atenolol, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Atenolol is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.